GLAUKOS Corp
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
GKOS$236.19-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Accumulated | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Additional · other | |||||||||
| Common stock · paid-in · comprehensive · Accumulated · Treasury stock · Total | |||||||||
| Shares · Amount · capital · (loss) income · deficit · Shares · Amount · equity | |||||||||
| Balance at December 31, 2022 | 47,782 | $48 | $997,470 | $(2,975) | $(464,406) | (28) | $(132) | $530,005 | |
| Common stock issued under stock plans, net | 1,366 | 1 | 15,753 | — | — | — | — | 15,754 | |
| Acquired in-process R&D acquired through the issuance of common stock | — | — | 3,000 | — | — | — | — | 3,000 | |
| Stock-based compensation | — | — | 43,528 | — | — | — | — | 43,528 | |
| Other comprehensive income | — | — | — | 4,140 | — | — | — | 4,140 | |
| Net loss | — | — | — | — | (134,661) | — | — | (134,661) | |
| Balance at December 31, 2023 | 49,148 | $49 | $1,059,751 | $1,165 | $(599,067) | (28) | $(132) | $461,766 | |
| Common stock issued under stock plans, net | 1,972 | 2 | 40,200 | — | — | — | — | 40,202 | |
| Issuance of common stock in exchange for convertible senior notes, net | 5,297 | 5 | 300,792 | — | — | — | — | 300,797 | |
| Unwinding of capped calls | — | — | 53,881 | — | — | 53,881 | |||
| Acquired in-process R&D acquired through the issuance of common stock | 55 | — | 5,000 | — | — | — | — | 5,000 | |
| Stock-based compensation | — | — | 50,207 | — | — | — | — | 50,207 | |
| Other comprehensive income | — | — | — | 1,450 | — | — | — | 1,450 | |
| Net loss | — | — | — | — | (146,372) | — | — | (146,372) | |
| Balance at December 31, 2024 | 56,472 | $56 | $1,509,831 | $2,615 | $(745,439) | (28) | $(132) | $766,931 | |
| Common stock issued under stock plans, net | 1,067 | 2 | 13,007 | — | — | — | — | 13,009 | |
| Stock-based compensation | — | — | 63,218 | — | — | — | — | 63,218 | |
| Other comprehensive income | — | — | — | 688 | — | — | — | 688 | |
| Net loss | — | — | — | — | (187,691) | — | — | (187,691) | |
| Balance at December 31, 2025 | 57,539 | $58 | $1,586,056 | $3,303 | $(933,130) | (28) | $(132) | $656,155 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.